Prarthana Sharma

Dr. Prarthana Sharma

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 October 2025 in Nutrients
Verified
Journal Article
Open access
PDF file
Prarthana SharmaPrarthana Sharma
Prarthana Sharma
Varunkumar AsediyaVarunkumar Asediya
Varunkumar Asediya
GKGarima Kalra
Garima Kalra
Sharmin SultanaSharmin Sultana
Sharmin Sultana
NPNihal Purohit
Nihal Purohit
MPMariusz Pierzchała
Mariusz Pierzchała
Silymarin, a flavonolignan-rich extract of Silybum marianum, is widely recognized for its hepatoprotective potential. While rodent studies predominate, pigs (Sus scrofa) offer a more translationally relevant model due to their hepatic architecture, bile acid composition, and transporter expression, which closely resemble those of humans. This narrative review synthesises current evidence on the chemistry, pharmacokinetics, biodistribution, and hepatoprotective activity of silymarin in porcine models. Available studies demonstrate that when adequate intrahepatic exposure is achieved, particularly through optimised formulations, silymarin can attenuate oxidative stress, suppress inflammatory signalling, stabilise mitochondria, and modulate fibrogenic pathways. Protective effects have been reported across diverse porcine injury paradigms, including toxin-induced necrosis, ethanol- and diet-associated steatosis, metabolic dysfunction, ischemia–reperfusion injury, and partial hepatectomy. However, the evidence base remains limited, with few long-term studies addressing fibrosis or regeneration, and methodological heterogeneity complicates the comparison of data across studies. Current knowledge gaps in silymarin research include inconsistent chemotype characterization among plant sources, limited reporting of unbound pharmacokinetic parameters, and variability in histological scoring criteria across studies, which collectively hinder cross-study comparability and mechanistic interpretation. Advances in analytical chemistry, transporter biology, and formulation design are beginning to refine the interpretation of exposure–response relationships. Advances in analytical chemistry, transporter biology, and formulation design are beginning to refine the interpretation of exposure–response relationships. In parallel, emerging computational approaches, including machine-learning-assisted chemotype fingerprinting, automated histology scoring, and Bayesian exposure modeling, are being explored as supportive tools to enhance reproducibility and translational relevance; however, these frameworks remain exploratory and require empirical validation, particularly in modeling enterohepatic recirculation. Collectively, current porcine evidence supports silymarin as a context-dependent yet credible hepatoprotective agent, highlighting priorities for future research to better define its therapeutic potential in clinical nutrition and veterinary practice.

26 January 2026 in Nutrients
Verified
Journal Article
Open access
PDF file
KKKamila Kibitlewska
Kamila Kibitlewska
Varunkumar AsediyaVarunkumar Asediya
Varunkumar Asediya
KKKrzysztof Karpiesiuk
Krzysztof Karpiesiuk
UCUrszula Czarnik
Urszula Czarnik
MLMarek Lucjusz Lecewicz
Marek Lucjusz Lecewicz
WKWojciech Kozera
Wojciech Kozera
Curcumin, the major polyphenolic constituent of Curcuma longa, has been widely investigated as a hepatoprotective adjunct due to its antioxidant and immunomodulatory properties. This review evaluates the relevance of curcumin for the prevention and management of liver dysfunction and hepatitis in pigs by synthesizing available porcine evidence and integrating mechanistic insights from translational liver injury models where pig-specific data remain limited. Across experimental hepatic injury contexts, curcumin administration is most consistently associated with reduced biochemical and structural indicators of hepatocellular damage, including decreased aminotransferase activity, attenuation of lipid peroxidation, and enhancement of endogenous antioxidant defenses. These effects are mechanistically linked to suppression of pro-inflammatory signaling pathways, particularly NF-κB-related transcriptional activity and inflammasome-associated responses, together with reduced expression of key cytokines such as TNF-α, IL-1β, and IL-6. Concurrent activation of Nrf2-centered cytoprotective pathways and induction of phase II antioxidant enzymes (including HO-1, GST, and NQO1) appear to constitute a conserved axis supporting hepatic oxidative stress resilience. In swine-relevant infectious settings, available data further support antiviral activity against selected porcine pathogens, including classical swine fever virus and porcine reproductive and respiratory syndrome virus, potentially mediated through interference with lipid-dependent stages of viral replication and modulation of Kupffer cell activation. Although combination strategies with established hepatoprotective approaches are conceptually attractive, current synergy evidence remains heterogeneous and largely extrapolated. Overall, curcumin represents a plausible adjunct candidate for supporting porcine liver health; however, translation into practice will depend on resolving formulation-dependent bioavailability constraints and strengthening the pig-specific evidence base.

19 April 2026 in SSRN Electronic Journal
Verified
Preprint
Open access
Sharmin SultanaSharmin Sultana
Sharmin Sultana
CPChandra Shekhar Pareek
Chandra Shekhar Pareek
Prarthana SharmaPrarthana Sharma
Prarthana Sharma
GKGarima Kalra
Garima Kalra
NPNihal Purohit
Nihal Purohit
MPMariusz Pierzchała
Mariusz Pierzchała
The systematic exclusion of degraded RNA samples presents a critical challenge in transcriptomic research, particularly for clinical specimens and archival biobanks where maximizing data recovery is imperative. This study describes a quality control workflow for microRNA sequencing (miRNA-Seq) that integrates chemical purity (A260/230) with the traditional RNA Integrity Number (RIN), as miRNA-Seq targets short RNA fragments that may remain detectable despite degradation of the total RNA pool. Porcine liver was utilized as a rigorous model for enzyme-rich, degradable tissues. Standard extraction was combined with multi-metric assessment and automated size selection (BluePippin) to manage heterogeneous quality and enrich small RNA. Shifting inclusion criteria toward chemical thresholds yielded 84 viable samples from 93, maintaining consistent purity (median A260/230 ≈ 1.63) despite substantial integrity variation (RIN < 3.0). High-throughput sequencing confirmed robustness, with library success exceeding 94% across all groups, including samples lacking quantifiable ribosomal bands. This method provides a data-driven basis for refining quality control criteria and supports reliable miRNA profiling from degraded porcine liver tissue samples. Integrates chemical purity (A260/230) metrics with RIN to improve sample selection for miRNA-Seq.Enables successful library preparation from severely degraded RNA samples.Provides a reproducible workflow combining multi-metric QC and automated size selection (BluePippin)

10 November 2025 in Translational Research in Veterinary Science
Verified
Journal Article
Open access
Prarthana SharmaPrarthana Sharma
Prarthana Sharma
The technical execution of single-cell RNA sequencing (scRNA-seq) in liver tissue poses notable challenges due to the inherent fragility of hepatocytes, the distinct metabolic zonation, and the rapid activation of stress-response mechanisms during tissue dissociation. These complications are further exacerbated in porcine liver, where the large size of hepatocytes and elevated endogenous RNase activity resemble human hepatic tissue, yet are particularly vulnerable to mechanical and enzymatic stresses. Conventional scRNA-seq methodologies frequently yield diminished cell viability, RNA degradation, and skewed representation of hepatic subpopulations when applied to porcine models. We introduce a reproducible and species-optimized protocol for conducting scRNA-seq on porcine liver. This methodology incorporates cold-active enzymatic dissociation, low-shear mechanical manipulation, RNase suppression, and debris-minimized density separation to maintain cellular integrity and transcriptomic accuracy. A brief in vitro stabilization phase further improves cell viability and mitigates ambient RNA contamination, yielding single-cell suspensions amenable to droplet-based systems, such as the 10× Genomics v3.1 and v4 chemistries. Benchmarking outcomes reveal high viability rates (>80%), substantial transcript complexity, and consistent recovery of both parenchymal and non-parenchymal populations with diminished stress-response profiles. This workflow establishes a standardized approach for high-fidelity, cross-institutional scRNA-seq investigations and bolsters translational research applications in toxicology, pharmacokinetics, and hepatoprotective therapies. Acknowledgement This research is financed and supported by the scientific project NCN-OPUSLAP (UMO-2021/43/I/NZ9/02612) entitled: Multilevel molecular analysis of the hepatoprotective effect of medicinal herbs extracts in prevention of liver dysfunction caused by aflatoxin B1 in pig as an animal model (in-vivo), and hepatocyte cell culture analysis in human and pig (in-vitro).